Related Experiment Video
Updated: Oct 4, 2025

Evaluation of Amino Acid Consumption in Cultured Bone Cells and Isolated Bone Shafts
Published on: April 13, 2022
Glutamine synthetase licenses APC/C-mediated mitotic progression to drive cell growth
Jiang-Sha Zhao1,2, Shuo Shi3, Hai-Yan Qu4
1Zhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China. zhaojsh@zju.edu.cn.
Abstract:
Tumors can reprogram the functions of metabolic enzymes to fuel malignant growth; however, beyond their conventional functions, key metabolic enzymes have not been found to directly govern cell mitosis. Here, we report that glutamine synthetase (GS) promotes cell proliferation by licensing mitotic progression independently of its metabolic function. GS depletion, but not impairment of its enzymatic activity, results in mitotic arrest and multinucleation across multiple lung and liver cancer cell lines, patient-derived organoids and xenografted tumors. Mechanistically, GS directly interacts with the nuclear pore protein NUP88 to prevent its binding to CDC20. Such interaction licenses activation of the CDC20-mediated anaphase-promoting complex or cyclosome to ensure proper metaphase-to-anaphase transition. In addition, GS is overexpressed in human non-small cell lung cancer and its depletion reduces tumor growth in mice and increases the efficacy of microtubule-targeted chemotherapy. Our findings highlight a moonlighting function of GS in governing mitosis and illustrate how an essential metabolic enzyme promotes cell proliferation and tumor development, beyond its main metabolic function.
Insights
Glutamine synthetase (GS) drives cancer cell proliferation by regulating mitosis, independent of its metabolic role. Depleting GS halts cancer growth and enhances chemotherapy, revealing a novel therapeutic target.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Metabolic enzymes are reprogrammed in tumors.
- Key metabolic enzymes have not been known to directly regulate cell mitosis.
- Glutamine synthetase (GS) is an essential metabolic enzyme.
Purpose of the Study:
- To investigate the non-metabolic functions of glutamine synthetase (GS).
- To determine if GS directly regulates cell mitosis and cancer proliferation.
- To explore GS as a potential therapeutic target in non-small cell lung cancer.
Main Methods:
- Depletion of GS in cancer cell lines, organoids, and xenografts.
- Assessing mitotic progression and cell cycle regulation.
- Investigating the interaction between GS, NUP88, and CDC20.
- Evaluating tumor growth and chemotherapy efficacy in mouse models.
Main Results:
- GS depletion, not enzymatic inhibition, caused mitotic arrest and multinucleation.
- GS directly interacts with NUP88, preventing its binding to CDC20.
- This interaction is crucial for the metaphase-to-anaphase transition.
- GS is overexpressed in non-small cell lung cancer, and its depletion reduced tumor growth and improved chemotherapy response.
Conclusions:
- Glutamine synthetase (GS) possesses a moonlighting function in governing cell mitosis.
- GS promotes cancer cell proliferation and tumor development beyond its metabolic role.
- Targeting GS offers a novel strategy for cancer therapy, particularly in combination with microtubule-targeting agents.
More Related Videos
Related Concept Videos
Anaphase Promoting Complex
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cells Coordinate Growth and Proliferation
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Abnormal Proliferation

